Cargando…
Sarcoidosis associated with infliximab therapy in ulcerative colitis: A case report
RATIONALE: Although immunomodulatory therapy has been clearly stated as an important landmark in treatment of ulcerative colitis, significantly improving the quality of life for patients with inflammatory bowel disease, there are several aspects to be considered regarding the possible side-effects o...
Autores principales: | Gîlcă, Georgiana-Emmanuela, Diaconescu, Smaranda, Bălan, Gheorghe Gh., Timofte, Oana, Ştefănescu, Gabriela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348151/ https://www.ncbi.nlm.nih.gov/pubmed/28272203 http://dx.doi.org/10.1097/MD.0000000000006156 |
Ejemplares similares
-
Split-dose or hybrid nonsteroidal anti-inflammatory drugs and N-acetylcysteine therapy for prevention of post-retrograde cholangiopancreatography pancreatitis
por: Pavel, Laura, et al.
Publicado: (2019) -
New Insights into the Role of Trace Elements in IBD
por: Gîlcă-Blanariu, Georgiana-Emmanuela, et al.
Publicado: (2018) -
Advances in Noninvasive Biomarkers for Nonalcoholic Fatty Liver Disease
por: Gîlcă-Blanariu, Georgiana-Emmanuela, et al.
Publicado: (2023) -
Functional Gastrointestinal Disorders with Psychiatric Symptoms: Involvement of the Microbiome–Gut–Brain Axis in the Pathophysiology and Case Management
por: Șchiopu, Cristina Gabriela, et al.
Publicado: (2022) -
Efficacy of infliximab, cyclosporine and tacrolimus on ulcerative colitis: A meta-analysis
por: Jia, Xuemei, et al.
Publicado: (2020)